Thu, 04 Jun 2020 19:38:24: What does it mean to #BeFierce? Our new look tells the story

Thu, 04 Jun 2020 12:14:33: GSK's cell therapy R&D lead jumps ship to partner Immatics

Thu, 04 Jun 2020 12:11:27: Broad Institute's new gene-editing technique restores hearing in mice

Thu, 04 Jun 2020 10:25:18: Spectrum Pharma nabs Five Prime, Gilead veteran as new clinical lead

Thu, 04 Jun 2020 09:42:01: Gilead shows durability of filgotinib ahead of face-off with AbbVie

Wed, 03 Jun 2020 13:47:29: Novellus snaps up BRAF cancer drug from Daiichi's biotech unit Plexxikon

Wed, 03 Jun 2020 12:21:08: Aduro, Chinook ink merger to take renal drug into phase 3 

Wed, 03 Jun 2020 10:21:47: Gene-edited T cells to treat diabetes inch closer to clinical trials

Tue, 02 Jun 2020 12:53:38: In conversation with Tom Lynch, president and director of Fred Hutchinson Cancer Research Center

Tue, 02 Jun 2020 12:22:14: Hahn: Permanently adopting R&D-accelerating COVID-19 measures is a top FDA priority

Tue, 02 Jun 2020 11:07:16: Pfizer to funnel $500M into biotechs, offering 'crucial capital' during the COVID-19 crisis

Tue, 02 Jun 2020 08:33:48: Stanford researcher Genovese joins Gilead to lead NASH, arthritis programs

Mon, 01 Jun 2020 13:29:34: I-MAB advances repositioned RA drug in early trial to treat COVID-19 cytokine storm

Mon, 01 Jun 2020 12:12:32: Lilly starts first clinical trial of COVID-19 antibody therapy

Mon, 01 Jun 2020 11:56:29: Regeneron boosts Intellia CRISPR pact with bleeding disorder focus, cash boost

Mon, 01 Jun 2020 11:28:07: AbbVie pens cancer pact with U.S.-China biotech Jacobio

Mon, 01 Jun 2020 10:40:14: Biotech IPO bonanza: Legend's $350M offering as Repare, Forma get in on the action

Fri, 29 May 2020 12:56:34: ASCO: Allogene reports 63% response rate in early trial of off-the-shelf CAR-T in lymphoma

Fri, 29 May 2020 11:06:30: Takeda culls Shire pipeline med after no one wants it

Fri, 29 May 2020 08:12:21: Ipsen names Sanofi Pasteur CEO Loew as new leader

Fri, 29 May 2020 08:08:26: COVID-19 vaccine leaders talk up the need for partners, potential for a working vax by October

Thu, 28 May 2020 18:06:22: Chutes & Ladders—Immunomedics CEO Semerjian out after short tenure

Thu, 28 May 2020 14:05:19: After passing safety hurdle, Orpheris kick-starts COVID-19 cytokine storm efficacy test

Thu, 28 May 2020 12:15:48: PureTech eyes clinical trial in long-term COVID-19 complications

Thu, 28 May 2020 11:50:22: Protalix, Chiesi edge close to potential Fabry disease approval